annual CFI:
$77.79M-$51.85M(-40.00%)Summary
- As of today (May 29, 2025), ADPT annual cash flow from investing activities is $77.79 million, with the most recent change of -$51.85 million (-40.00%) on December 31, 2024.
- During the last 3 years, ADPT annual CFI has fallen by -$103.42 million (-57.07%).
- ADPT annual CFI is now -57.07% below its all-time high of $181.21 million, reached on December 31, 2021.
Performance
ADPT Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$25.57M+$3.45M(+15.62%)Summary
- As of today (May 29, 2025), ADPT quarterly cash flow from investing activities is $25.57 million, with the most recent change of +$3.45 million (+15.62%) on March 31, 2025.
- Over the past year, ADPT quarterly CFI has dropped by -$18.94 million (-42.54%).
- ADPT quarterly CFI is now -85.59% below its all-time high of $177.49 million, reached on June 30, 2020.
Performance
ADPT quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$58.86M-$18.94M(-24.34%)Summary
- As of today (May 29, 2025), ADPT TTM cash flow from investing activities is $58.86 million, with the most recent change of -$18.94 million (-24.34%) on March 31, 2025.
- Over the past year, ADPT TTM CFI has dropped by -$52.32 million (-47.06%).
- ADPT TTM CFI is now -78.18% below its all-time high of $269.69 million, reached on September 30, 2020.
Performance
ADPT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ADPT Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -40.0% | -42.5% | -47.1% |
| 3 y3 years | -57.1% | -32.1% | -52.9% |
| 5 y5 years | +116.2% | -82.1% | +150.4% |
ADPT Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -57.1% | +2577.9% | -59.4% | +126.2% | -64.9% | +1926.0% |
| 5 y | 5-year | -57.1% | +116.2% | -85.6% | +107.5% | -78.2% | +119.5% |
| alltime | all time | -57.1% | +116.2% | -85.6% | +107.5% | -78.2% | +111.8% |
ADPT Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $25.57M(+15.6%) | $58.86M(-24.3%) |
| Dec 2024 | $77.79M(-40.0%) | $22.12M(+318.4%) | $77.79M(+32.1%) |
| Sep 2024 | - | $5.29M(-10.0%) | $58.88M(-26.2%) |
| Jun 2024 | - | $5.88M(-86.8%) | $79.73M(-28.3%) |
| Mar 2024 | - | $44.51M(+1287.9%) | $111.18M(-14.2%) |
| Dec 2023 | $129.65M(+4362.9%) | $3.21M(-87.7%) | $129.65M(+348.7%) |
| Sep 2023 | - | $26.14M(-30.0%) | $28.90M(-52.5%) |
| Jun 2023 | - | $37.32M(-40.7%) | $60.77M(+115.5%) |
| Mar 2023 | - | $62.98M(-164.6%) | $28.20M(+870.6%) |
| Dec 2022 | $2.90M(-98.4%) | -$97.54M(-268.1%) | $2.90M(-98.3%) |
| Sep 2022 | - | $58.02M(+1122.4%) | $167.66M(+89.7%) |
| Jun 2022 | - | $4.75M(-87.4%) | $88.38M(-29.3%) |
| Mar 2022 | - | $37.69M(-43.9%) | $125.08M(-31.0%) |
| Dec 2021 | $181.21M | $67.21M(-416.0%) | $181.21M(-180.2%) |
| Sep 2021 | - | -$21.27M(-151.3%) | -$226.05M(-25.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $41.45M(-55.8%) | -$302.03M(+82.0%) |
| Mar 2021 | - | $93.82M(-127.6%) | -$165.98M(+41.8%) |
| Dec 2020 | -$117.04M(-75.7%) | -$340.05M(+249.7%) | -$117.04M(-143.4%) |
| Sep 2020 | - | -$97.25M(-154.8%) | $269.69M(+154.2%) |
| Jun 2020 | - | $177.49M(+24.3%) | $106.08M(-190.9%) |
| Mar 2020 | - | $142.76M(+205.8%) | -$116.76M(-75.8%) |
| Dec 2019 | -$481.70M(<-9900.0%) | $46.68M(-117.9%) | -$481.70M(-3.8%) |
| Sep 2019 | - | -$260.85M(+475.2%) | -$500.75M(+113.3%) |
| Jun 2019 | - | -$45.35M(-79.6%) | -$234.76M(+27.1%) |
| Mar 2019 | - | -$222.18M(-904.1%) | -$184.75M(<-9900.0%) |
| Dec 2018 | $736.00K(-98.0%) | $27.63M(+438.3%) | $736.00K(-102.7%) |
| Sep 2018 | - | $5.13M(+10.1%) | -$26.89M(-16.0%) |
| Jun 2018 | - | $4.66M(-112.7%) | -$32.03M(-12.7%) |
| Mar 2018 | - | -$36.69M | -$36.69M |
| Dec 2017 | $36.43M | - | - |
FAQ
- What is Adaptive Biotechnologies annual cash flow from investing activities?
- What is the all time high annual CFI for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies annual CFI year-on-year change?
- What is Adaptive Biotechnologies quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies quarterly CFI year-on-year change?
- What is Adaptive Biotechnologies TTM cash flow from investing activities?
- What is the all time high TTM CFI for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies TTM CFI year-on-year change?
What is Adaptive Biotechnologies annual cash flow from investing activities?
The current annual CFI of ADPT is $77.79M
What is the all time high annual CFI for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high annual cash flow from investing activities is $181.21M
What is Adaptive Biotechnologies annual CFI year-on-year change?
Over the past year, ADPT annual cash flow from investing activities has changed by -$51.85M (-40.00%)
What is Adaptive Biotechnologies quarterly cash flow from investing activities?
The current quarterly CFI of ADPT is $25.57M
What is the all time high quarterly CFI for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high quarterly cash flow from investing activities is $177.49M
What is Adaptive Biotechnologies quarterly CFI year-on-year change?
Over the past year, ADPT quarterly cash flow from investing activities has changed by -$18.94M (-42.54%)
What is Adaptive Biotechnologies TTM cash flow from investing activities?
The current TTM CFI of ADPT is $58.86M
What is the all time high TTM CFI for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high TTM cash flow from investing activities is $269.69M
What is Adaptive Biotechnologies TTM CFI year-on-year change?
Over the past year, ADPT TTM cash flow from investing activities has changed by -$52.32M (-47.06%)